Carasent Asa (OSE: CARA) Q2 2025 Earnings | 07/10/2025

15 days ago

1:11:45

Inside Ticker

Earnings Calls

About this video

Carasent Asa (OSE: CARA) reported Q2 2025 results on July 10, 2025, with net sales up 26% year-over-year to SEK 82.9 million and EBITDA rising 55% to SEK 12.1 million. Organic growth was 13%, and recurring revenue grew 25%. The company signed a major contract with Medtanken and expanded its AI-driven digital health solutions, though profitability was impacted by restructuring and tech investments. Carasent revised its 2025 revenue guidance to SEK 345–350 million and EBITDA to SEK 75 million, focusing on margin expansion and operational efficiency. Outlook: Continued investment in AI, digital health, and recurring revenue Focus on cost control, customer engagement, and product innovation About Inside Ticker: For more expert analysis and real-time updates on Carasent Asa (OSE: CARA) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports and financial insights. #Carasent #CARA #Q22025 #Earnings #HealthTech #DigitalHealth #AI #Growth #Innovation #RecurringRevenue #ARR #HealthcareIT #Medtanken #Profitability #OperationalEfficiency #Restructuring #CostControl #PrimaryCare #SaaS #TechStocks #NordicTech #InvestorUpdate #InsideTicker #FinancialResults #healthcaretransformation

Important Note: The stock market is inherently unpredictable, and forecasts are subject to change based on various factors, including economic conditions and company performance. Always consult multiple sources and consider professional advice before making investment decisions.

AI-Powered Financial Analysis This analysis uses real-time market data. While we strive for accuracy, always verify important financial information and consult with qualified financial professionals before making investment decisions. Past performance does not guarantee future results.